Categories: News

NHI Announces First Quarter 2022 Earnings Release and Conference Call Date

MURFREESBORO, TN / ACCESSWIRE / April 20, 2022 / National Health Investors, Inc. (NYSE:NHI) announced details for the release of its results for the first quarter ended March 31, 2022. NHI plans to issue its earnings release after the market closes on Monday, May 9, 2022, and will host a conference call on the following day, Tuesday, May 10, 2022, at 12:00 p.m. Eastern Time to discuss the results. The number to call for this interactive teleconference is (800) 941-4658, with the confirmation number 22016962.

The live broadcast of the conference call will be available online at www.nhireit.com and at https://www.webcaster4.com/Webcast/Page/633/45019 on Tuesday, May 10, 2022, at 12:00 p.m. Eastern Time. The online replay will be available shortly after the call and remain available for one year.

About NHI

Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI’s portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals. For more information, visit www.nhireit.com.

Contact:

Dana Hambly, Vice President, Finance and Investor Relations
Phone: (615) 890-9100

SOURCE: National Health Investors

View source version on accesswire.com:
https://www.accesswire.com/698198/NHI-Announces-First-Quarter-2022-Earnings-Release-and-Conference-Call-Date

Staff

Recent Posts

Sona’s Cancer Therapy Triggers Abscopal Effect, Eliminating Distant Tumors In Preclinical Melanoma Study

Halifax, Nova Scotia--(Newsfile Corp. - June 26, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB:…

47 mins ago

Bemax Inc. Announces UK Distribution Hub for Reduced Lead Time on Orders

Dallas, Georgia--(Newsfile Corp. - June 26, 2024) - Bemax Inc. (OTC Pink: BMXC), a private…

2 hours ago

Lifeward Unveils Newest Addition to Its AlterG Anti-Gravity Product Line – Introducing AlterG NEO

Elevate your practice and revolutionize patient care with the all-new user-friendly design and the same…

2 hours ago

BioStem Technologies Reports Breakthrough Results with AmnioWrap2® in Retrospective Wound Care Study

Study published in peer-reviewed journal finds BioStem’s products offer overall better treatment efficiency, and greater…

2 hours ago

Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UK

AXA is the 2nd Largest Provider of Private Medical Insurance in the UK Payer Coverage…

2 hours ago

University of Nebraska Medical Center Launches Patient Enrollment for RenovoRx’s Pivotal Phase III TIGeR-PaC Clinical Trial

Ongoing Study is Investigating RenovoGem™ to treat Locally Advanced Pancreatic CancerLOS ALTOS, Calif., June 26, 2024…

2 hours ago